Official announcements
Safety warnings
|
Blood & Tissue
|
12/06/2026
The Federal Office for Safety in Health Care (BASG) has been informed by the Italian authorities that a human WNV infection has been recorded in Italy in the current season in the province of Caserta/Campania region.
messages in brief
Veterinary Medicines
|
08/06/2026
In accordance with Article 152 of Regulation (EU) 2019/6, all marketing authorisations for veterinary medicinal products (VMPs) granted under Directive 2001/82/EC, as amended, must be updated to align their product information with QRD template version 9.These updates must be completed at the latest by 29 January 2027, after which all products placed on the market must have product information compliant with QRD v9.
Safety warnings
|
Blood & Tissue
|
01/06/2026
The Federal Office for Safety in Health Care (BASG) has been informed by the ECDC (European Centre for Disease Prevention and Control) that human WNV infections have been recorded in North Macedonia, in Vardar.
Safety warnings
|
Medicines
|
29/05/2026
Precautionary batch recall, as there may be glass splinters in the bottles
Recall
|
Medicines
|
29/05/2026
Recall due to possible contamination with glass splinters
Recall
|
Medicines
|
29/05/2026
Recall due to reduced release of active pharmaceutical ingredient
Enforcement
|
27/05/2026
Many of the offered "peptides" are classified as medicinal products without marketing authorisation by the Austrian Federal Office for Safety in Health Care (BASG) depending on their composition, concentration, effects and scientific data.
Enforcement
|
27/05/2026
The BASG warns against illegal medicinal products (illegal medicinal product by presentation) marketed under the misleading name "GLP-1" because of their claims.
Safety warnings
|
Medical devices
|
27/05/2026
The Federal Office for Safety in Health Care (BASG) warns of a counterfeit medical device that could be mistaken for the legitimate product "Juvéderm Ultra 4" from the manufacturer "Allergan Aesthetics, an AbbVie company".
Safety warnings
|
Medical devices
|
26/05/2026
The Federal Office for Safety in Health Care (BASG) warns against the use of rapid tests for the detection of sexually transmitted diseases (STDs) that were distributed via the website „thuistest.shop“ and “stdheimtest.de“. Based on the information available to the BASG, the legal compliance of the affected products cannot be sufficiently demonstrated and therefore the safety and performance of the products cannot be ensured. For this reason, the listed products are not allowed to be placed on the Union Market.